Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

NCT04564716 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Collaborators